399 related articles for article (PubMed ID: 29507273)
1. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM; Ezzat DA; Doudar NA; Adel M
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[TBL] [Abstract][Full Text] [Related]
3. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
[TBL] [Abstract][Full Text] [Related]
4. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S; Nozu K; Maeta S; Yamamura T; Nakanishi K; Fujimura J; Horinouchi T; Nagano C; Sakakibara N; Nagase H; Shima H; Noda K; Ninchoji T; Kaito H; Iijima K
Sci Rep; 2018 Nov; 8(1):17322. PubMed ID: 30470792
[TBL] [Abstract][Full Text] [Related]
5. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
Pediatr Nephrol; 2015 Feb; 30(2):309-16. PubMed ID: 25142334
[TBL] [Abstract][Full Text] [Related]
6. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[TBL] [Abstract][Full Text] [Related]
7. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[TBL] [Abstract][Full Text] [Related]
8. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[TBL] [Abstract][Full Text] [Related]
9. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
10. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[TBL] [Abstract][Full Text] [Related]
11. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
Rumana J; Hanif M; Muinuddin G; Maruf-Ul-Quader M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):830-6. PubMed ID: 24969196
[TBL] [Abstract][Full Text] [Related]
12. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
Cara-Fuentes G; Lanaspa MA; Garcia GE; Banks M; Garin EH; Johnson RJ
Pediatr Nephrol; 2018 Jul; 33(7):1101-1103. PubMed ID: 29492674
[TBL] [Abstract][Full Text] [Related]
13. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
[TBL] [Abstract][Full Text] [Related]
15. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Cara-Fuentes G; Wasserfall CH; Wang H; Johnson RJ; Garin EH
Pediatr Nephrol; 2014 Dec; 29(12):2333-40. PubMed ID: 25017621
[TBL] [Abstract][Full Text] [Related]
16. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J; Schenk H; Schiffer M
Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
Kurasawa S; Kato S; Ozeki T; Akiyama S; Ishimoto T; Mizuno M; Tsuboi N; Kato N; Kosugi T; Maruyama S;
Clin Exp Nephrol; 2024 May; 28(5):431-439. PubMed ID: 38267800
[TBL] [Abstract][Full Text] [Related]
18. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP; Chhabra P; Narayan G; Srivastava P; Prasad R; Singh A; Abhinay A; Batra VV
Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
[TBL] [Abstract][Full Text] [Related]
20. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
Gong X; Huang J; Zhang Y; Wang F; Wang X; Meng L; Cheng X; Liu G; Cui Z; Zhao M
Ren Fail; 2023; 45(2):2279642. PubMed ID: 37942512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]